Synthetic Biology Technology Comprehensive Study by Type (Synthetic DNA, Synthetic Genes, Software Tools, Synthetic Cells, Chassis Organisms), Application (Pharmaceuticals & Diagnostics, Chemicals, Biofuels, Bioplastics, Others), Technology (Genetic Engineering, Bioinformatics, Microfluidics) Players and Region - Global Market Outlook to 2026

Synthetic Biology Technology Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Synthetic Biology Technology Market Scope?
Synthetic biology is the science of designing, altering, and building easy organisms to perform specific therapeutic or industrial utilities. The commercialization of industrialization of biology renders processes faster, cheaper, and reliable. The organisms created are called genetically changed organisms (GMOs), which don't need a definition that distinguishes them from genetic modifications. The growth of artificial biology in the aid market is attributed to the increasing investments, technological advancement and rising numbers of start-up companies that are boosting the market over the years. Additionally, the rising trends of synthetic biology are probably to possess a positive impact on the growth of the market within the coming years.

The Synthetic Biology Technology market study is being classified by Type (Synthetic DNA, Synthetic Genes, Software Tools, Synthetic Cells and Chassis Organisms), by Application (Pharmaceuticals & Diagnostics, Chemicals, Biofuels, Bioplastics and Others) and major geographies with country level break-up.

The need for technology is increasing because of the increasing emerging awareness about synthetic biology. Synthetic biology is an upcoming field and industry, which has numerous applications in the chemical, agriculture, pharmaceutical, and energy sectors. There are various start-up companies that are providing products/services for biological processes. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Synthetic Biology Technology market throughout the predicted period.

Thermo Fisher Scientific, Inc. (United States), Merck KGaA (Germany), Agilent Technologies, Inc (United States), Novozymes A/S (Denmark), Ginkgo Bioworks (United States), Amyris (United States), Precigen, Inc. (United States), GenScript (China), Twist Bioscience (United States), Synthetic Genomics (United States), Codexis (United States), Synthego (United States), Creative Enzymes (United States) and Eurofins Scientific (Luxembourg) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Synthetic Biology Technology market by Type, Application and Region.

On the basis of geography, the market of Synthetic Biology Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • The Increasing Involvement of Government Bodies
  • The Increasing Application of Genome Editing in Agriculture

Market Drivers
  • Rising Demand for Bio-Fuels
  • Growing Awareness in Emerging Economies
  • Rising R&D Investments for Synthetic Drugs

Opportunities
  • Advancement In the Field of Biotechnology
  • The Rise in The Investment Is Enabling Technological Developments

Restraints
  • High Cost of The Technology

Challenges
  • Reimbursement Cuts Causing Pricing Pressure


Key Target Audience
Providers of Synthetic Biology Technology, Governmental and Regulatory bodies and End-Users

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Synthetic DNA
  • Synthetic Genes
  • Software Tools
  • Synthetic Cells
  • Chassis Organisms
By Application
  • Pharmaceuticals & Diagnostics
  • Chemicals
  • Biofuels
  • Bioplastics
  • Others
By Technology
  • Genetic Engineering
  • Bioinformatics
  • Microfluidics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Demand for Bio-Fuels
      • 3.2.2. Growing Awareness in Emerging Economies
      • 3.2.3. Rising R&D Investments for Synthetic Drugs
    • 3.3. Market Challenges
      • 3.3.1. Reimbursement Cuts Causing Pricing Pressure
    • 3.4. Market Trends
      • 3.4.1. The Increasing Involvement of Government Bodies
      • 3.4.2. The Increasing Application of Genome Editing in Agriculture
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Synthetic Biology Technology, by Type, Application, Technology and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Synthetic Biology Technology (Value)
      • 5.2.1. Global Synthetic Biology Technology by: Type (Value)
        • 5.2.1.1. Synthetic DNA
        • 5.2.1.2. Synthetic Genes
        • 5.2.1.3. Software Tools
        • 5.2.1.4. Synthetic Cells
        • 5.2.1.5. Chassis Organisms
      • 5.2.2. Global Synthetic Biology Technology by: Application (Value)
        • 5.2.2.1. Pharmaceuticals & Diagnostics
        • 5.2.2.2. Chemicals
        • 5.2.2.3. Biofuels
        • 5.2.2.4. Bioplastics
        • 5.2.2.5. Others
      • 5.2.3. Global Synthetic Biology Technology by: Technology (Value)
        • 5.2.3.1. Genetic Engineering
        • 5.2.3.2. Bioinformatics
        • 5.2.3.3. Microfluidics
      • 5.2.4. Global Synthetic Biology Technology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Synthetic Biology Technology (Price)
      • 5.3.1. Global Synthetic Biology Technology by: Type (Price)
  • 6. Synthetic Biology Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck KGaA (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agilent Technologies, Inc (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novozymes A/S (Denmark)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ginkgo Bioworks (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Amyris (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Precigen, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GenScript (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Twist Bioscience (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Synthetic Genomics (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Codexis (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Synthego (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Creative Enzymes (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Eurofins Scientific (Luxembourg)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Synthetic Biology Technology Sale, by Type, Application, Technology and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Synthetic Biology Technology (Value)
      • 7.2.1. Global Synthetic Biology Technology by: Type (Value)
        • 7.2.1.1. Synthetic DNA
        • 7.2.1.2. Synthetic Genes
        • 7.2.1.3. Software Tools
        • 7.2.1.4. Synthetic Cells
        • 7.2.1.5. Chassis Organisms
      • 7.2.2. Global Synthetic Biology Technology by: Application (Value)
        • 7.2.2.1. Pharmaceuticals & Diagnostics
        • 7.2.2.2. Chemicals
        • 7.2.2.3. Biofuels
        • 7.2.2.4. Bioplastics
        • 7.2.2.5. Others
      • 7.2.3. Global Synthetic Biology Technology by: Technology (Value)
        • 7.2.3.1. Genetic Engineering
        • 7.2.3.2. Bioinformatics
        • 7.2.3.3. Microfluidics
      • 7.2.4. Global Synthetic Biology Technology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Synthetic Biology Technology (Price)
      • 7.3.1. Global Synthetic Biology Technology by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Synthetic Biology Technology: by Type(USD Million)
  • Table 2. Synthetic Biology Technology Synthetic DNA , by Region USD Million (2015-2020)
  • Table 3. Synthetic Biology Technology Synthetic Genes , by Region USD Million (2015-2020)
  • Table 4. Synthetic Biology Technology Software Tools , by Region USD Million (2015-2020)
  • Table 5. Synthetic Biology Technology Synthetic Cells , by Region USD Million (2015-2020)
  • Table 6. Synthetic Biology Technology Chassis Organisms , by Region USD Million (2015-2020)
  • Table 7. Synthetic Biology Technology: by Application(USD Million)
  • Table 8. Synthetic Biology Technology Pharmaceuticals & Diagnostics , by Region USD Million (2015-2020)
  • Table 9. Synthetic Biology Technology Chemicals , by Region USD Million (2015-2020)
  • Table 10. Synthetic Biology Technology Biofuels , by Region USD Million (2015-2020)
  • Table 11. Synthetic Biology Technology Bioplastics , by Region USD Million (2015-2020)
  • Table 12. Synthetic Biology Technology Others , by Region USD Million (2015-2020)
  • Table 13. Synthetic Biology Technology: by Technology(USD Million)
  • Table 14. Synthetic Biology Technology Genetic Engineering , by Region USD Million (2015-2020)
  • Table 15. Synthetic Biology Technology Bioinformatics , by Region USD Million (2015-2020)
  • Table 16. Synthetic Biology Technology Microfluidics , by Region USD Million (2015-2020)
  • Table 17. South America Synthetic Biology Technology, by Country USD Million (2015-2020)
  • Table 18. South America Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 19. South America Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 20. South America Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 21. Brazil Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 22. Brazil Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 23. Brazil Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 24. Argentina Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 25. Argentina Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 26. Argentina Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 27. Rest of South America Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 28. Rest of South America Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 29. Rest of South America Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 30. Asia Pacific Synthetic Biology Technology, by Country USD Million (2015-2020)
  • Table 31. Asia Pacific Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 32. Asia Pacific Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 33. Asia Pacific Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 34. China Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 35. China Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 36. China Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 37. Japan Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 38. Japan Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 39. Japan Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 40. India Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 41. India Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 42. India Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 43. South Korea Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 44. South Korea Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 45. South Korea Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 46. Taiwan Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 47. Taiwan Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 48. Taiwan Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 49. Australia Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 50. Australia Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 51. Australia Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 55. Europe Synthetic Biology Technology, by Country USD Million (2015-2020)
  • Table 56. Europe Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 57. Europe Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 58. Europe Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 59. Germany Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 60. Germany Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 61. Germany Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 62. France Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 63. France Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 64. France Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 65. Italy Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 66. Italy Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 67. Italy Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 68. United Kingdom Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 69. United Kingdom Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 70. United Kingdom Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 71. Netherlands Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 72. Netherlands Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 73. Netherlands Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 74. Rest of Europe Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 75. Rest of Europe Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 76. Rest of Europe Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 77. MEA Synthetic Biology Technology, by Country USD Million (2015-2020)
  • Table 78. MEA Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 79. MEA Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 80. MEA Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 81. Middle East Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 82. Middle East Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 83. Middle East Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 84. Africa Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 85. Africa Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 86. Africa Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 87. North America Synthetic Biology Technology, by Country USD Million (2015-2020)
  • Table 88. North America Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 89. North America Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 90. North America Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 91. United States Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 92. United States Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 93. United States Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 94. Canada Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 95. Canada Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 96. Canada Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 97. Mexico Synthetic Biology Technology, by Type USD Million (2015-2020)
  • Table 98. Mexico Synthetic Biology Technology, by Application USD Million (2015-2020)
  • Table 99. Mexico Synthetic Biology Technology, by Technology USD Million (2015-2020)
  • Table 100. Synthetic Biology Technology: by Type(USD/Units)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Synthetic Biology Technology: by Type(USD Million)
  • Table 116. Synthetic Biology Technology Synthetic DNA , by Region USD Million (2021-2026)
  • Table 117. Synthetic Biology Technology Synthetic Genes , by Region USD Million (2021-2026)
  • Table 118. Synthetic Biology Technology Software Tools , by Region USD Million (2021-2026)
  • Table 119. Synthetic Biology Technology Synthetic Cells , by Region USD Million (2021-2026)
  • Table 120. Synthetic Biology Technology Chassis Organisms , by Region USD Million (2021-2026)
  • Table 121. Synthetic Biology Technology: by Application(USD Million)
  • Table 122. Synthetic Biology Technology Pharmaceuticals & Diagnostics , by Region USD Million (2021-2026)
  • Table 123. Synthetic Biology Technology Chemicals , by Region USD Million (2021-2026)
  • Table 124. Synthetic Biology Technology Biofuels , by Region USD Million (2021-2026)
  • Table 125. Synthetic Biology Technology Bioplastics , by Region USD Million (2021-2026)
  • Table 126. Synthetic Biology Technology Others , by Region USD Million (2021-2026)
  • Table 127. Synthetic Biology Technology: by Technology(USD Million)
  • Table 128. Synthetic Biology Technology Genetic Engineering , by Region USD Million (2021-2026)
  • Table 129. Synthetic Biology Technology Bioinformatics , by Region USD Million (2021-2026)
  • Table 130. Synthetic Biology Technology Microfluidics , by Region USD Million (2021-2026)
  • Table 131. South America Synthetic Biology Technology, by Country USD Million (2021-2026)
  • Table 132. South America Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 133. South America Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 134. South America Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 135. Brazil Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 136. Brazil Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 137. Brazil Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 138. Argentina Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 139. Argentina Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 140. Argentina Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 141. Rest of South America Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 142. Rest of South America Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 143. Rest of South America Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 144. Asia Pacific Synthetic Biology Technology, by Country USD Million (2021-2026)
  • Table 145. Asia Pacific Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 146. Asia Pacific Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 147. Asia Pacific Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 148. China Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 149. China Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 150. China Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 151. Japan Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 152. Japan Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 153. Japan Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 154. India Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 155. India Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 156. India Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 157. South Korea Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 158. South Korea Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 159. South Korea Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 160. Taiwan Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 161. Taiwan Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 162. Taiwan Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 163. Australia Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 164. Australia Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 165. Australia Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 166. Rest of Asia-Pacific Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 167. Rest of Asia-Pacific Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 168. Rest of Asia-Pacific Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 169. Europe Synthetic Biology Technology, by Country USD Million (2021-2026)
  • Table 170. Europe Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 171. Europe Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 172. Europe Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 173. Germany Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 174. Germany Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 175. Germany Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 176. France Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 177. France Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 178. France Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 179. Italy Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 180. Italy Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 181. Italy Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 182. United Kingdom Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 183. United Kingdom Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 184. United Kingdom Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 185. Netherlands Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 186. Netherlands Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 187. Netherlands Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 188. Rest of Europe Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 189. Rest of Europe Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 190. Rest of Europe Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 191. MEA Synthetic Biology Technology, by Country USD Million (2021-2026)
  • Table 192. MEA Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 193. MEA Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 194. MEA Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 195. Middle East Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 196. Middle East Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 197. Middle East Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 198. Africa Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 199. Africa Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 200. Africa Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 201. North America Synthetic Biology Technology, by Country USD Million (2021-2026)
  • Table 202. North America Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 203. North America Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 204. North America Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 205. United States Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 206. United States Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 207. United States Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 208. Canada Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 209. Canada Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 210. Canada Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 211. Mexico Synthetic Biology Technology, by Type USD Million (2021-2026)
  • Table 212. Mexico Synthetic Biology Technology, by Application USD Million (2021-2026)
  • Table 213. Mexico Synthetic Biology Technology, by Technology USD Million (2021-2026)
  • Table 214. Synthetic Biology Technology: by Type(USD/Units)
  • Table 215. Research Programs/Design for This Report
  • Table 216. Key Data Information from Secondary Sources
  • Table 217. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Synthetic Biology Technology: by Type USD Million (2015-2020)
  • Figure 5. Global Synthetic Biology Technology: by Application USD Million (2015-2020)
  • Figure 6. Global Synthetic Biology Technology: by Technology USD Million (2015-2020)
  • Figure 7. South America Synthetic Biology Technology Share (%), by Country
  • Figure 8. Asia Pacific Synthetic Biology Technology Share (%), by Country
  • Figure 9. Europe Synthetic Biology Technology Share (%), by Country
  • Figure 10. MEA Synthetic Biology Technology Share (%), by Country
  • Figure 11. North America Synthetic Biology Technology Share (%), by Country
  • Figure 12. Global Synthetic Biology Technology: by Type USD/Units (2015-2020)
  • Figure 13. Global Synthetic Biology Technology share by Players 2020 (%)
  • Figure 14. Global Synthetic Biology Technology share by Players (Top 3) 2020(%)
  • Figure 15. Global Synthetic Biology Technology share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2020
  • Figure 19. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Merck KGaA (Germany) Revenue: by Geography 2020
  • Figure 21. Agilent Technologies, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 22. Agilent Technologies, Inc (United States) Revenue: by Geography 2020
  • Figure 23. Novozymes A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 24. Novozymes A/S (Denmark) Revenue: by Geography 2020
  • Figure 25. Ginkgo Bioworks (United States) Revenue, Net Income and Gross profit
  • Figure 26. Ginkgo Bioworks (United States) Revenue: by Geography 2020
  • Figure 27. Amyris (United States) Revenue, Net Income and Gross profit
  • Figure 28. Amyris (United States) Revenue: by Geography 2020
  • Figure 29. Precigen, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Precigen, Inc. (United States) Revenue: by Geography 2020
  • Figure 31. GenScript (China) Revenue, Net Income and Gross profit
  • Figure 32. GenScript (China) Revenue: by Geography 2020
  • Figure 33. Twist Bioscience (United States) Revenue, Net Income and Gross profit
  • Figure 34. Twist Bioscience (United States) Revenue: by Geography 2020
  • Figure 35. Synthetic Genomics (United States) Revenue, Net Income and Gross profit
  • Figure 36. Synthetic Genomics (United States) Revenue: by Geography 2020
  • Figure 37. Codexis (United States) Revenue, Net Income and Gross profit
  • Figure 38. Codexis (United States) Revenue: by Geography 2020
  • Figure 39. Synthego (United States) Revenue, Net Income and Gross profit
  • Figure 40. Synthego (United States) Revenue: by Geography 2020
  • Figure 41. Creative Enzymes (United States) Revenue, Net Income and Gross profit
  • Figure 42. Creative Enzymes (United States) Revenue: by Geography 2020
  • Figure 43. Eurofins Scientific (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 44. Eurofins Scientific (Luxembourg) Revenue: by Geography 2020
  • Figure 45. Global Synthetic Biology Technology: by Type USD Million (2021-2026)
  • Figure 46. Global Synthetic Biology Technology: by Application USD Million (2021-2026)
  • Figure 47. Global Synthetic Biology Technology: by Technology USD Million (2021-2026)
  • Figure 48. South America Synthetic Biology Technology Share (%), by Country
  • Figure 49. Asia Pacific Synthetic Biology Technology Share (%), by Country
  • Figure 50. Europe Synthetic Biology Technology Share (%), by Country
  • Figure 51. MEA Synthetic Biology Technology Share (%), by Country
  • Figure 52. North America Synthetic Biology Technology Share (%), by Country
  • Figure 53. Global Synthetic Biology Technology: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific, Inc. (United States)
  • Merck KGaA (Germany)
  • Agilent Technologies, Inc (United States)
  • Novozymes A/S (Denmark)
  • Ginkgo Bioworks (United States)
  • Amyris (United States)
  • Precigen, Inc. (United States)
  • GenScript (China)
  • Twist Bioscience (United States)
  • Synthetic Genomics (United States)
  • Codexis (United States)
  • Synthego (United States)
  • Creative Enzymes (United States)
  • Eurofins Scientific (Luxembourg)
Select User Access Type

Key Highlights of Report


Jun 2021 218 Pages 92 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Synthetic Biology Technology market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Synthetic Biology Technology market are Thermo Fisher Scientific, Inc. (United States), Merck KGaA (Germany), Agilent Technologies, Inc (United States), Novozymes A/S (Denmark), Ginkgo Bioworks (United States), Amyris (United States), Precigen, Inc. (United States), GenScript (China), Twist Bioscience (United States), Synthetic Genomics (United States), Codexis (United States), Synthego (United States), Creative Enzymes (United States) and Eurofins Scientific (Luxembourg), to name a few.
In this highly competitive & fast evolving Synthetic Biology Technology industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Synthetic Biology Technology Report?